Epidemiological Trends and Resistance Associated with Stenotrophomonas maltophilia Bacteremia: A 10-Year Retrospective Cohort Study in a Tertiary-Care Hospital in Hungary

Stenotrophomonas maltophilia has been recognized as an emerging nosocomial pathogen in invasive infections of immunocompromised, severely debilitated patients with significant underlying illnesses. The first-choice drug in these infections is sulfamethoxazole-trimethoprim (SMX/TMP), and resistance t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gajdács, Márió, Urbán, Edit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631814/
https://www.ncbi.nlm.nih.gov/pubmed/31159258
http://dx.doi.org/10.3390/diseases7020041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631814/
https://www.ncbi.nlm.nih.gov/pubmed/31159258
http://dx.doi.org/10.3390/diseases7020041

Ejemplares similares